Get In Touch

Acromegaly is a rare hormonal disease that is caused due to excess production of growth hormone in adults. The condition acromegaly is usually caused by a pituitary tumor. The term acro means extremities and megaly means enlargement of; thus, acromegaly refers to enlargement of hands and feet. Gigantism is also a hormonal disorder which is caused due to excessive production of the growth hormone during childhood. The disorder is characterized by over bone growth and abnormal height. Acromegaly and gigantism are considered serious illnesses and are life-threatening.

The global acromegaly and gigantism treatment market is expected to expand at a steady CAGR during the forecast period. Acromegaly and gigantism is a rare disease and according to a journal, Pituitary, the total prevalence of acromegaly ranges from 2.8 to 13.7 cases per 1 lakh people each year. The increasing prevalence of the disease is one of the important factors projected to drive the growth of the global acromegaly and gigantism market through 2025. According to the American Cancer Society, around ten thousand pituitary tumors are diagnosed in America each year. Such a high prevalence rate of this tumor is one of the most important factors augmenting the growth of the global market. Furthermore, rise in prevalence of other chronic disorders such as carney complex, McCune- Albright Syndrome, development of novel therapy for treatment etc. are factors anticipated to drive the growth of the global acromegaly and gigantism market during the forecast period. Lack of awareness about the diagnosis and management of the disorder in many developing countries is the major restraining factor of the market.

The global acromegaly and gigantism treatment market can be segmented into treatment, end users, and geographical expansion. On the basis of treatment, the market is divided into surgery, radiation therapy, and medication. The medication segment can be further divided into different drug types such as somatostatin analogs, GH receptor antagonists, dopamine agonists and others. The medication segment is expected to hold a significant market share during the forecast period due to factors such as effectiveness of drugs, noninvasive and lesser side effects than radiation therapies, and strong pipeline portfolio. The global acromegaly and gigantism treatment market, on the basis of end users is segmented into hospitals, clinics, home care settings and others.

Geographically the acromegaly and gigantism treatment market is divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the global market with the largest share. Increase in prevalence of pituitary tumors in the region leading to acromegaly and gigantism is one of the major factors driving the growth of the market in the region. Furthermore, advanced technology, rise in awareness among people about diagnosis of the disease, high healthcare expenditure etc. are some of the factors attributed to the growth of the market in North America. Europe is also anticipated to hold a significant share of the global market due to factors such as increase in healthcare investment in the region, focus of new entrants etc. The Asia Pacific market is anticipated to register a faster growth rate during the forecast period. Asia Pacific is the most lucrative market due to adoption of healthcare solutions for better standard of life, rise in healthcare awareness, and increase in healthcare expenditure etc.

To maintain a significant position in the market, key players are following strategies such as mergers and acquisitions, cost effective and efficient drugs, collaborative partnerships etc. Some of the prominent players operating in the acromegaly and gigantism treatment market are Pfizer Inc., Chiasma, Inc., Novartis AG, Crinetics Pharmaceuticals, Ionis Pharmaceuticals Inc., and Midatech Pharma Plc among others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Acromegaly Gigantism Treatment Market

Pre Book